🇺🇸 FDA
Patent

US 6187306

Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same

expired A61KA61K2039/5152A61K2039/5156

Quick answer

US patent 6187306 (Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5152, A61K2039/5156, A61K2039/55522, A61K39/00